These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract in Cystic Fibrosis. Patel D; Jose F; Baker J; Moshiree B Curr Gastroenterol Rep; 2024 Jan; 26(1):9-19. PubMed ID: 38057499 [TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal, Pancreatic, and Hepatobiliary Manifestations of Cystic Fibrosis. Sathe MN; Freeman AJ Pediatr Clin North Am; 2016 Aug; 63(4):679-98. PubMed ID: 27469182 [TBL] [Abstract][Full Text] [Related]
5. Year in review 2020: Nutrition and gastrointestinal disease in cystic fibrosis. Sathe M; Sharma PB; Savant AP Pediatr Pulmonol; 2021 Oct; 56(10):3120-3125. PubMed ID: 34310872 [TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal and Hepatobiliary Disease in Cystic Fibrosis. Gabel ME; Galante GJ; Freedman SD Semin Respir Crit Care Med; 2019 Dec; 40(6):825-841. PubMed ID: 31659728 [TBL] [Abstract][Full Text] [Related]
7. Management of pancreatic, gastrointestinal and liver complications in adult cystic fibrosis. Munck A; Languepin J; Debray D; Lamireau T; Abely M; Huet F; Maudinas R; Michaud L; Mas E Rev Mal Respir; 2015 Jun; 32(6):566-85. PubMed ID: 26001957 [TBL] [Abstract][Full Text] [Related]
12. Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators. Konrad J; Eber E; Stadlbauer V Paediatr Respir Rev; 2022 Jun; 42():9-16. PubMed ID: 33485777 [TBL] [Abstract][Full Text] [Related]
13. Advancing the GI frontier for patients with CF. Freedman SD; Wilschanski M; Schwarzenberg SJ J Cyst Fibros; 2018 Jan; 17(1):1-2. PubMed ID: 29208346 [No Abstract] [Full Text] [Related]
14. Beyond pancreatic insufficiency and liver disease in cystic fibrosis. Demeyer S; De Boeck K; Witters P; Cosaert K Eur J Pediatr; 2016 Jul; 175(7):881-94. PubMed ID: 27055450 [TBL] [Abstract][Full Text] [Related]
18. Designing the GALAXY study: Partnering with the cystic fibrosis community to optimize assessment of gastrointestinal symptoms. Freeman AJ; Sathe M; Aliaj E; Borowitz D; Fogarty B; Goss CH; Freedman S; Heltshe SL; Khan U; Riva D; Roman C; Romasco M; Schwarzenberg SJ; Ufret-Vincenty CA; Moshiree B J Cyst Fibros; 2021 Jul; 20(4):598-604. PubMed ID: 33451899 [TBL] [Abstract][Full Text] [Related]
19. Bacterial overgrowth, dysbiosis, inflammation, and dysmotility in the Cystic Fibrosis intestine. Dorsey J; Gonska T J Cyst Fibros; 2017 Nov; 16 Suppl 2():S14-S23. PubMed ID: 28986022 [TBL] [Abstract][Full Text] [Related]
20. A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders. Hayee B; Watson KL; Campbell S; Simpson A; Farrell E; Hutchings P; Macedo P; Perrin F; Whelan K; Elston C United European Gastroenterol J; 2019 Aug; 7(7):881-888. PubMed ID: 31428412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]